Test results under the UNLCSL path. by Zhezhe Zhang (19704587)

“…Under the same <i>JRC</i>, σ_<i>i</i> increases with the increase of τ₁, and Δσ_n decreases with the increasing τ₁. Under the same <i>JRC</i> and σ_<i>i</i>, τ_<i>i</i> is significantly smaller under the UNLCSL path than the CNL path. …”

Average relative error of τ_<i>i</i>. by Zhezhe Zhang (19704587)

“…Under the same <i>JRC</i>, σ_<i>i</i> increases with the increase of τ₁, and Δσ_n decreases with the increasing τ₁. Under the same <i>JRC</i> and σ_<i>i</i>, τ_<i>i</i> is significantly smaller under the UNLCSL path than the CNL path. …”

Test scheme. by Zhezhe Zhang (19704587)

“…Under the same <i>JRC</i>, σ_<i>i</i> increases with the increase of τ₁, and Δσ_n decreases with the increasing τ₁. Under the same <i>JRC</i> and σ_<i>i</i>, τ_<i>i</i> is significantly smaller under the UNLCSL path than the CNL path. …”

Average relative error of τ_<i>i</i>. by Zhezhe Zhang (19704587)

“…Under the same <i>JRC</i>, σ_<i>i</i> increases with the increase of τ₁, and Δσ_n decreases with the increasing τ₁. Under the same <i>JRC</i> and σ_<i>i</i>, τ_<i>i</i> is significantly smaller under the UNLCSL path than the CNL path. …”

Preparation process of concrete joint specimens. by Zhezhe Zhang (19704587)

“…Under the same <i>JRC</i>, σ_<i>i</i> increases with the increase of τ₁, and Δσ_n decreases with the increasing τ₁. Under the same <i>JRC</i> and σ_<i>i</i>, τ_<i>i</i> is significantly smaller under the UNLCSL path than the CNL path. …”

Cohesion correction coefficient. by Zhezhe Zhang (19704587)

“…Under the same <i>JRC</i>, σ_<i>i</i> increases with the increase of τ₁, and Δσ_n decreases with the increasing τ₁. Under the same <i>JRC</i> and σ_<i>i</i>, τ_<i>i</i> is significantly smaller under the UNLCSL path than the CNL path. …”

Fig 18 in each curve fitting results. by Zhezhe Zhang (19704587)

“…Under the same <i>JRC</i>, σ_<i>i</i> increases with the increase of τ₁, and Δσ_n decreases with the increasing τ₁. Under the same <i>JRC</i> and σ_<i>i</i>, τ_<i>i</i> is significantly smaller under the UNLCSL path than the CNL path. …”

Fig 29 in each curve fitting results. by Zhezhe Zhang (19704587)

“…Under the same <i>JRC</i>, σ_<i>i</i> increases with the increase of τ₁, and Δσ_n decreases with the increasing τ₁. Under the same <i>JRC</i> and σ_<i>i</i>, τ_<i>i</i> is significantly smaller under the UNLCSL path than the CNL path. …”

Fig 9(b) in the straight-line fitting results. by Zhezhe Zhang (19704587)

“…Under the same <i>JRC</i>, σ_<i>i</i> increases with the increase of τ₁, and Δσ_n decreases with the increasing τ₁. Under the same <i>JRC</i> and σ_<i>i</i>, τ_<i>i</i> is significantly smaller under the UNLCSL path than the CNL path. …”

Specimen packaging process. by Zhezhe Zhang (19704587)

“…Under the same <i>JRC</i>, σ_<i>i</i> increases with the increase of τ₁, and Δσ_n decreases with the increasing τ₁. Under the same <i>JRC</i> and σ_<i>i</i>, τ_<i>i</i> is significantly smaller under the UNLCSL path than the CNL path. …”

Example of a choice set for Best Worst Scaling. by Yachiyo Tobita (20613887)

“…The timing of these studies coincides with the onset of the COVID-19 pandemic in early 2020 and the outbreak of the Russia-Ukraine war in February 2022. The findings revealed a 19.9% decrease in the average monthly cost of living per capita between 2018 and 2022, attributed to the combined effects of rising food prices and unemployment. …”

<b> </b> Rate of brain weight to body weight in different experimental groups. AlCl3 treatment caused a significant decrease in brain-to-body weight with respect to the control group (P < 0.01). 2 or 5 injections of BM-MSC extracted exosomes significantly protected against the deficit effect of Alcl3 on brain-to-body weight rate.... by Atefeh Sadeghi (21253051)

“…AlCl3 treatment caused a significant decrease in brain-to-body weight with respect to the control group (P < 0.01). 2 or 5 injections of BM-MSC extracted exosomes significantly protected against the deficit effect of Alcl3 on brain-to-body weight rate. …”

Relationship between τ_<i>i</i> and σ_<i>i</i>. by Zhezhe Zhang (19704587)

“…Under the same <i>JRC</i>, σ_<i>i</i> increases with the increase of τ₁, and Δσ_n decreases with the increasing τ₁. Under the same <i>JRC</i> and σ_<i>i</i>, τ_<i>i</i> is significantly smaller under the UNLCSL path than the CNL path. …”

The relationship between Δσ_n and τ₁, <i>JRC</i>. by Zhezhe Zhang (19704587)

“…Under the same <i>JRC</i>, σ_<i>i</i> increases with the increase of τ₁, and Δσ_n decreases with the increasing τ₁. Under the same <i>JRC</i> and σ_<i>i</i>, τ_<i>i</i> is significantly smaller under the UNLCSL path than the CNL path. …”

Relationship between τ_<i>i</i> and σ_<i>i</i>. by Zhezhe Zhang (19704587)

“…Under the same <i>JRC</i>, σ_<i>i</i> increases with the increase of τ₁, and Δσ_n decreases with the increasing τ₁. Under the same <i>JRC</i> and σ_<i>i</i>, τ_<i>i</i> is significantly smaller under the UNLCSL path than the CNL path. …”

Novel Small-Molecule miR-124 Inducer Acts as “a Physiological Brake” of Inflammation in Ulcerative Colitis by Targeting the PIK3R2/PI3K/Akt Axis by Tiantian Wang (1688881)

“…We found that FHND5032 significantly upregulated miR-124 expression in macrophages, surpassing the clinical-stage comparator ABX464 in vitro and in vivo. …”

Difference in various variables with different PA level. by Zixia Bu (21475019)

Demographic information of participants. by Zixia Bu (21475019)

“…The longitudinal results showed a decreasing trend of negative correlation between AB and PA under T1-T3 stages (r = −0.29, r = −0.44, P < 0.01), and no significant change in the degree of negative correlation with HSK (r = −0.28, r = −0.35, P < 0.01). …”

Evogliptin attenuates the pyroptotic cell death of VSMCs during CER treatment by decreasing the pyroptotic-associated genes and GSDM-D cleavage efficiency <i>in-vitro.</i> by Razia Rashid Rahil (22772495)

“…<p>(A) Bar graph showed EVO significantly decreased Lactate dehydrogenase (LDH) release in CER treated P_i‐induced VSMCs. …”

Development of alpha diversity across weeks towards a new TNF treatment for each IBD disease subtype. by Katrine Carlsen (5477300)